Literature DB >> 30319179

Effects of MRI scanner parameters on breast cancer radiomics.

Ashirbani Saha1, Xiaozhi Yu1, Dushyant Sahoo1, Maciej A Mazurowski1,2,3.   

Abstract

PURPOSE: To assess the impact of varying magnetic resonance imaging (MRI) scanner parameters on the extraction of algorithmic features in breast MRI radiomics studies.
METHODS: In this retrospective study, breast imaging data for 272 patients were analyzed with magnetic resonance (MR) images. From the MR images, we assembled and implemented 529 algorithmic features of breast tumors and fibrograndular tissue (FGT). We divided the features into 10 groups based on the type of data used for the feature extraction and the nature of the extracted information. Three scanner parameters were considered: scanner manufacturer, scanner magnetic field strength, and slice thickness. We assessed the impact of each of the scanner parameters on each of the feature by testing whether the feature values are systematically diverse for different values of these scanner parameters. A two-sample t-test has been used to establish whether the impact of a scanner parameter on values of a feature is significant and receiver operating characteristics have been used for to establish the extent of that effect.
RESULTS: On average, higher proportion (69% FGT versus 20% tumor) of FGT related features were affected by the three scanner parameters. Of all feature groups and scanner parameters, the feature group related to the variation in FGT enhancement was found to be the most sensitive to the scanner manufacturer (AUC = 0.81 ± 0.14).
CONCLUSIONS: Features involving calculations from FGT are particularly sensitive to the scanner parameters.

Entities:  

Keywords:  ROC analysis; breast cancer MRI radiomics; computer-extracted features MRI; magnetic field strength; scanner manufacturer; slice thickness

Year:  2017        PMID: 30319179      PMCID: PMC6176866          DOI: 10.1016/j.eswa.2017.06.029

Source DB:  PubMed          Journal:  Expert Syst Appl        ISSN: 0957-4174            Impact factor:   6.954


  52 in total

1.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard.

Authors:  Francesco Sardanelli; Gian M Giuseppetti; Pietro Panizza; Massimo Bazzocchi; Alfonso Fausto; Giovanni Simonetti; Vincenzo Lattanzio; Alessandro Del Maschio
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

2.  Influence of MRI acquisition protocols and image intensity normalization methods on texture classification.

Authors:  G Collewet; M Strzelecki; F Mariette
Journal:  Magn Reson Imaging       Date:  2004-01       Impact factor: 2.546

Review 3.  How to optimize clinical breast MR imaging practices and techniques on Your 1.5-T system.

Authors:  Dana R Rausch; R Edward Hendrick
Journal:  Radiographics       Date:  2006 Sep-Oct       Impact factor: 5.333

4.  Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.

Authors:  Maciej A Mazurowski; Jing Zhang; Lars J Grimm; Sora C Yoon; James I Silber
Journal:  Radiology       Date:  2014-07-15       Impact factor: 11.105

5.  Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.

Authors:  Elizabeth J Sutton; Jung Hun Oh; Brittany Z Dashevsky; Harini Veeraraghavan; Aditya P Apte; Sunitha B Thakur; Joseph O Deasy; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2015-04-07       Impact factor: 4.813

6.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

Review 7.  Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions.

Authors:  S H Heywang-Köbrunner; P Viehweg; A Heinig; C Küchler
Journal:  Eur J Radiol       Date:  1997-02       Impact factor: 3.528

8.  Radiogenomics: what it is and why it is important.

Authors:  Maciej A Mazurowski
Journal:  J Am Coll Radiol       Date:  2015-08       Impact factor: 5.532

9.  Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging.

Authors:  Nariya Cho; Seock-Ah Im; In-Ae Park; Kyung-Hun Lee; Mulan Li; Wonshik Han; Dong-Young Noh; Woo Kyung Moon
Journal:  Radiology       Date:  2014-04-13       Impact factor: 11.105

10.  Assessing Agreement between Radiomic Features Computed for Multiple CT Imaging Settings.

Authors:  Lin Lu; Ross C Ehmke; Lawrence H Schwartz; Binsheng Zhao
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

View more
  16 in total

1.  Association of distant recurrence-free survival with algorithmically extracted MRI characteristics in breast cancer.

Authors:  Maciej A Mazurowski; Ashirbani Saha; Michael R Harowicz; Elizabeth Hope Cain; Jeffrey R Marks; P Kelly Marcom
Journal:  J Magn Reson Imaging       Date:  2019-01-22       Impact factor: 4.813

2.  Deep learning for identifying radiogenomic associations in breast cancer.

Authors:  Zhe Zhu; Ehab Albadawy; Ashirbani Saha; Jun Zhang; Michael R Harowicz; Maciej A Mazurowski
Journal:  Comput Biol Med       Date:  2019-04-25       Impact factor: 4.589

3.  A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study.

Authors:  Marie-Judith Saint Martin; Fanny Orlhac; Pia Akl; Fahad Khalid; Christophe Nioche; Irène Buvat; Caroline Malhaire; Frédérique Frouin
Journal:  MAGMA       Date:  2020-11-12       Impact factor: 2.310

4.  Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.

Authors:  Elizabeth Hope Cain; Ashirbani Saha; Michael R Harowicz; Jeffrey R Marks; P Kelly Marcom; Maciej A Mazurowski
Journal:  Breast Cancer Res Treat       Date:  2018-10-16       Impact factor: 4.872

Review 5.  Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Authors:  Ashirbani Saha; Samantha Tso; Jessica Rabski; Alireza Sadeghian; Michael D Cusimano
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

6.  Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence.

Authors:  Jieun Koh; Eunjung Lee; Kyunghwa Han; Sujeong Kim; Dong-Kyu Kim; Jin Young Kwak; Jung Hyun Yoon; Hee Jung Moon
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

7.  Robustness of radiomic features of benign breast lesions and hormone receptor positive/HER2-negative cancers across DCE-MR magnet strengths.

Authors:  Heather M Whitney; Karen Drukker; Alexandra Edwards; John Papaioannou; Milica Medved; Gregory Karczmar; Maryellen L Giger
Journal:  Magn Reson Imaging       Date:  2021-06-24       Impact factor: 3.130

8.  Quantitative variations in texture analysis features dependent on MRI scanning parameters: A phantom model.

Authors:  Karen Buch; Hirofumi Kuno; Muhammad M Qureshi; Baojun Li; Osamu Sakai
Journal:  J Appl Clin Med Phys       Date:  2018-10-27       Impact factor: 2.102

9.  Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer.

Authors:  Matthias Dietzel; Rüdiger Schulz-Wendtland; Stephan Ellmann; Ramy Zoubi; Evelyn Wenkel; Matthias Hammon; Paola Clauser; Michael Uder; Ingo B Runnebaum; Pascal A T Baltzer
Journal:  Sci Rep       Date:  2020-02-28       Impact factor: 4.379

10.  Radiomic Features of Multiparametric MRI Present Stable Associations With Analogous Histological Features in Patients With Brain Cancer.

Authors:  Samuel A Bobholz; Allison K Lowman; Alexander Barrington; Michael Brehler; Sean McGarry; Elizabeth J Cochran; Jennifer Connelly; Wade M Mueller; Mohit Agarwal; Darren O'Neill; Andrew S Nencka; Anjishnu Banerjee; Peter S LaViolette
Journal:  Tomography       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.